Last updated on November 2018

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis


Other Details:

- Physical exam and assessments of study condition to be provided at no cost by an experienced provider.
- No insurance necessary.
- Compensation will be provided for time and travel for all completed study visits.
- Stipend range: up to $540.00.



Find a site near you

Start Over

Sadick Research Group

911 Park Avenue, Ste. 1A New York, NY United States
  Connect »